Figure 1.
Molecular structures of the ionic liquids (ILs) employed, including: (a) allylbenzyldimethylammonium acetate (AlBzMe2NAcO); (b) 1-(2-methoxyethyl)-3-methylimidazolium acetate (C3OMeImAcO); (c) 1,8-diazabicyclo[5.4.0]undec-7-ene-8-ium acetate (DBUHAcO); (d) tetramethylguanidinium acetate (TMGHAcO).
